Review of Fecal Biomarkers in Inflammatory Bowel Disease
โ Scribed by Andrew D. Sutherland; Richard B. Gearry; Frank A. Frizelle
- Publisher
- Springer
- Year
- 2008
- Tongue
- English
- Weight
- 175 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0012-3706
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Background: Fecal calprotectin (FC) has been proposed as a noninvasive surrogate marker to determine the degree of intestinal inflammation and predicting relapse in patients with inflammatory bowel disease (IBD). The aim was to compare FC levels in IBD and healthy controls, to correlate FC levels wi
There is an increasing interest in the discovery of new inflammatory bowel disease (IBD) biomarkers able to predict the future patterns of disease and to help in diagnosis, treatment, and prognosis. A biomarker is a substance that can be measured biologically and is associated with an increased risk
## Background: Fecal calprotectin is a sensitive marker for gut inflammation. recently, we have established that a related protein, s100a12, is elevated in the feces of children with inflammatory bowel disease (ibd). this may represent a specific and sensitive disease marker. the objective was to i
Background: Several studies suggest an increased risk of venous and arterial thromboembolism (TE) in adults with inflammatory bowel disease (IBD) compared to the general population. We performed a systematic review of studies on incidence and characteristic of TE in children with IBD. Methods: We s